Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Balance Sheets

v3.25.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Current Assets:    
Cash and cash equivalents $ 23,415 $ 35,469
Restricted cash 2,258 742
Accounts receivable, net of allowance for credit losses of $76 and $23, respectively 55,069 58,217
Inventories 61,676 49,914
Transferable tax credits, net 7,500
Derivative instruments 525 3,313
Other current assets 5,474 5,463
Total current assets 155,917 153,118
Property and equipment, net 198,501 214,742
Other Assets:    
Right of use operating lease assets, net 16,931 20,553
Intangible assets, net 7,574 4,509
Other assets 9,863 8,516
Total other assets 34,368 33,578
Total Assets 388,786 401,438
Current Liabilities:    
Accounts payable 14,509 20,369
Accrued liabilities 16,691 24,214
Current portion – long-term debt 16,600
Current portion – operating leases 4,958 4,851
Derivative instruments 1,067 1,177
Other current liabilities 5,246 7,193
Total current liabilities 59,071 57,804
Long-term debt, net 63,027 92,904
Operating leases, net of current portion 13,012 16,913
Other liabilities 8,435 8,754
Total Liabilities 143,545 176,375
Commitments and contingencies
Stockholders’ Equity:    
Preferred stock, value
Common stock value 77 77
Additional paid-in capital 1,051,795 1,044,176
Accumulated other comprehensive income 5,461 4,975
Accumulated deficit (812,093) (824,166)
Total stockholders’ equity 245,241 225,063
Total Liabilities and Stockholders’ Equity 388,786 401,438
Series A Preferred Stock    
Stockholders’ Equity:    
Preferred stock, value
Series B Preferred Stock    
Stockholders’ Equity:    
Preferred stock, value 1 1
Non-Voting Common Stock    
Stockholders’ Equity:    
Common stock value